Gong Lian-Sheng, Zhang Yang-De, Liu Su
Department of Hepatobiliary and Enteric Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):365-8.
Liver cancer is one of the most common diseases around the world. The aim of this study was to verify the effect of magnetic field application on target distribution of nanoparticles in transplanted rat liver cancer model and to find out a new method for the treatment of malignant liver tumor.
Seven days after the establishment of the model, the abdomen of the rat was exposed through a midline abdominal incision. A cannula was inserted into the gastro-duodenal artery. In the experimental group (12 rats), the tumor tissue was exposed to the magnetic field for 30 minutes. Magnetic albumin nanoparticles containing adriamycin or at an equal dose of free adriamycin (0.5 mg/kg) were injected into the hepatic artery. After the magnetic field was removed, the rat was immediately sacrificed. An equal dose of nanoparticles in absence of the magnetic field served as control (12 rats). Tissues of tumor, nontargeted sites of the liver, heart, kidney, lung, spleen, stomach and small intestine were analyzed for gamma-counts and examined histologically.
In the experimental group, the radioactivity of tumor tissue was 8.7 times that of liver tissue. In the control group, the radioactivity of tumor tissue was 2.8 times that of normal liver tissue. The radioactivity of the lung was reduced more significantly in the experimental group than in the control group. No significant difference in the kidney, heart, spleen, small intestine and stomach was observed between the experimental group and control group. And over 80% of the injected nanoparticles distributed in the liver.
In the presence of magnetic field, magnetic albumin nanoparticles may accumulate in tumor tissues, of which the radioactivity can increase to 8.7 times that of normal liver. Even if the magnetic field is not applied, magnetic albumin nanoparticles in tumor tissues still increase to 2.8 times that of normal liver tissues. These findings indicate that normal organs in the presence of magnetic field are less exposed to chemotherapeutic drugs.
肝癌是全球最常见的疾病之一。本研究旨在验证磁场应用对移植性大鼠肝癌模型中纳米颗粒靶向分布的影响,并找出一种治疗恶性肝肿瘤的新方法。
模型建立7天后,经腹部正中切口暴露大鼠腹部。将套管插入胃十二指肠动脉。在实验组(12只大鼠)中,将肿瘤组织暴露于磁场30分钟。将含阿霉素的磁性白蛋白纳米颗粒或等量游离阿霉素(0.5mg/kg)注入肝动脉。去除磁场后,立即处死大鼠。在无磁场条件下注入等量纳米颗粒作为对照组(12只大鼠)。对肿瘤、肝脏非靶向部位、心脏、肾脏、肺、脾脏、胃和小肠组织进行γ计数分析并进行组织学检查。
实验组肿瘤组织放射性是肝脏组织的8.7倍。对照组肿瘤组织放射性是正常肝脏组织的2.8倍。实验组肺的放射性降低比对照组更显著。实验组和对照组在肾脏、心脏、脾脏、小肠和胃方面未观察到显著差异。且超过80%的注入纳米颗粒分布在肝脏。
在磁场存在的情况下,磁性白蛋白纳米颗粒可能在肿瘤组织中蓄积,其放射性可增加至正常肝脏的8.7倍。即使不施加磁场,肿瘤组织中的磁性白蛋白纳米颗粒仍增加至正常肝脏组织的2.8倍。这些发现表明在磁场存在时正常器官较少暴露于化疗药物。